Trademark: 88383848
Status Date
Monday, November 7, 2022
Filing Date
Friday, April 12, 2019
Published for Opposition
Tuesday, August 6, 2019
Abandoned Date
Monday, November 7, 2022
5 Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for the prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment and prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a pill or capsule that facilitate the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer
Nov 7, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 7, 2022
Abandonment - No Use Statement Filed
Mar 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2022
Sou Extension 5 Granted
Mar 17, 2022
Sou Extension 5 Filed
Mar 17, 2022
Teas Extension Received
Sep 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 21, 2021
Sou Extension 4 Granted
Sep 21, 2021
Sou Extension 4 Filed
Sep 21, 2021
Teas Extension Received
Jun 10, 2021
Teas Change Of Correspondence Received
Jun 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 7, 2021
Notice Of Approval Of Extension Request E-Mailed
May 6, 2021
Sou Extension 3 Granted
Apr 1, 2021
Sou Extension 3 Filed
May 4, 2021
Notice Of Revival - E-Mailed
May 3, 2021
Extension Received With Teas Petition
May 3, 2021
Petition To Revive-Granted
May 3, 2021
Teas Petition To Revive Received
May 3, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
May 3, 2021
Abandonment - No Use Statement Filed
Dec 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 10, 2020
Sou Extension 2 Granted
Oct 1, 2020
Sou Extension 2 Filed
Nov 3, 2020
Notice Of Revival - E-Mailed
Nov 3, 2020
Extension Received With Teas Petition
Nov 3, 2020
Petition To Revive-Granted
Nov 3, 2020
Teas Petition To Revive Received
Nov 2, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 2, 2020
Abandonment - No Use Statement Filed
Jul 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 10, 2020
Sou Extension 1 Granted
Apr 1, 2020
Sou Extension 1 Filed
Jul 10, 2020
Case Assigned To Intent To Use Paralegal
Jun 15, 2020
Notice Of Revival - E-Mailed
Jun 13, 2020
Extension Received With Teas Petition
Jun 13, 2020
Petition To Revive-Granted
Jun 13, 2020
Teas Petition To Revive Received
Jun 8, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 8, 2020
Abandonment - No Use Statement Filed
Oct 1, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 6, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2019
Published For Opposition
Jul 17, 2019
Notification Of Notice Of Publication E-Mailed
Jun 29, 2019
Approved For Pub - Principal Register
Jun 25, 2019
Examiner's Amendment Entered
Jun 25, 2019
Assigned To Lie
Jun 25, 2019
Notification Of Examiners Amendment E-Mailed
Jun 25, 2019
Examiners Amendment E-Mailed
Jun 25, 2019
Examiners Amendment -Written
Jun 22, 2019
Assigned To Examiner
Apr 30, 2019
New Application Office Supplied Data Entered In Tram
Apr 16, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
